SCHEMBL20920201

SCHEMBL20920201

FC(F)(F)c1ccc(CN2CN=C(SCc3ccccc3CSC3=NCN(Cc4ccc(C(F)(F)F)cc4)CN3)NC2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ MAPT P10636 1/20 0.40
▸ TOP2A P11388 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ KMT2A Q03164 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ ALOX15B O15296 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ BCHE P06276 2/20 0.37
▸ ACHE P22303 2/20 0.37
▸ BACE1 P56817 2/20 0.37
▸ CHKA P35790 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ OPRL1 P41146 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20917786 0.91 ALOX15B (0.46) KDM4EALDH1A1MAPTMAPK1LMNA
SCHEMBL20932763 0.90 MAPT (0.41) ALDH1A1MAPTTOP2ACYP3A4MAPK1
SCHEMBL22263137 0.86 MAPK1 (0.50) ALDH1A1MAPK1KMT2ALMNACYP1A2
SCHEMBL20918028 0.85 CYP1A2 (0.44) KDM4EALDH1A1CYP3A4MAPK1KMT2A
SCHEMBL19019919 0.82 HIF1A (0.47) KDM4EMAPTCYP3A4MAPK1KMT2A
SCHEMBL22263126 0.81 HTT (0.41) KDM4EALDH1A1MAPTMAPK1KMT2A
SCHEMBL20920186 0.81 CYP1A2 (0.49) KDM4EALDH1A1MAPTCYP3A4MAPK1
SCHEMBL20920185 0.81 CYP1A2 (0.42) KDM4EMAPTMAPK1KMT2ALMNA
SCHEMBL20917797 0.81 MAPT (0.47) ALDH1A1MAPTCYP3A4MAPK1ALOX15B
SCHEMBL22262985 0.80 GPR84 (0.38) ALDH1A1MAPTTOP2ACYP3A4MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250092020-A1 IDO/TDO Inhibitor GENERAL INCORPORATED ASSOCIATION PHARMA VALLEY PROJECT SUPPORTING ORGANIZATION (JP) 2025-03-20 — — US disclosed
US-12209079-B2 IDO/TDO inhibitor GENERAL INCORPORATED ASSOCIATION PHARMA VALLEY PROJECT SUPPORTING ORGANIZATION (JP) 2025-01-28 — — US disclosed
US-20220380305-A1 IDO/TDO Inhibitor CANBAS CO., LTD. 2022-12-01 — — US disclosed
US-20200239452-A1 IDO/TDO Inhibitor CANBAS CO., LTD. (JP) 2020-07-30 — — US disclosed
US-20200239452-A1 IDO/TDO Inhibitor CANBAS CO., LTD. (JP) 2020-07-30 — — US disclosed
WO-2019078246-A1 IDO/TDO INHIBITOR 一般社団法人ファルマバレープロジェクト支援機構 2019-04-25 — — WO disclosed
WO-2019078246-A1 IDO/TDO INHIBITOR 一般社団法人ファルマバレープロジェクト支援機構 2019-04-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12209079-B2 IDO/TDO inhibitor IDO1, IDO2, TDO2 KDM4E 1315/4885ALDH1A1 3331/4885MAPT 609/4885
US-20200239452-A1 IDO/TDO Inhibitor IDO1, IDO2, TDO2 KDM4E 1315/4885ALDH1A1 3331/4885MAPT 609/4885
US-20250092020-A1 IDO/TDO Inhibitor IDO1, IDO2, TDO2 KDM4E 1315/4885ALDH1A1 3331/4885MAPT 609/4885
US-20220380305-A1 IDO/TDO Inhibitor IDO1, IDO2, TDO2 KDM4E 751/4885ALDH1A1 3591/4885MAPT 614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback